Monthly Archives: December 2019

Kyn to Ikena: The Art and Science of Rebranding
December 17, 2019

This blog was written by Mark Manfredi, CEO of Ikena Oncology, and guest blogger Maude Tessier, CBO, as part of the From The Trenches feature of LifeSciVC. When we started to think about changing our company name, we knew it

Leave a comment

Our 2019 Year In Review: Macro, Biotech, and Atlas
December 13, 2019

It’s that time of year again when we pause to reflect on the state of the industry – and there’s more to focus on in biopharma today than just the drug pricing debate. As I described last year, we host

Leave a comment

Venturing A Perspective On The Drug Pricing Debate
December 10, 2019

The perennial drug pricing debate has reached a fever pitch, as loud as it’s ever been over the past few decades. Politicians on both sides are bashing the drug industry with the typical talking points about exorbitant prices, countered of

Leave a comment